tradingkey.logo

AVITA Medical Inc

RCEL

5.250USD

+0.090+1.74%
Market hours ETQuotes delayed by 15 min
138.78MMarket Cap
LossP/E TTM

AVITA Medical Inc

5.250

+0.090+1.74%
More Details of AVITA Medical Inc Company
AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.
Company Info
Ticker SymbolRCEL
Company nameAVITA Medical Inc
IPO dateMar 18, 2012
CEOMr. James M. (Jim) Corbett
Number of employees260
Security typeOrdinary Share
Fiscal year-endMar 18
Address28159 Avenue Stanford
CityVALENCIA
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code91355
Phone16613679170
Websitehttps://www.avitamedical.com/
Ticker SymbolRCEL
IPO dateMar 18, 2012
CEOMr. James M. (Jim) Corbett
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
29.63K
-27.07%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. James M. (Jim) Corbett
Mr. James M. (Jim) Corbett
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Lou Panaccio
Mr. Lou Panaccio
Independent Non-Executive Chairman of the board
Independent Non-Executive Chairman of the board
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
29.63K
-27.07%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. James M. (Jim) Corbett
Mr. James M. (Jim) Corbett
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
No Data
By RegionUSD
Name
Revenue
Proportion
United States
17.76M
95.91%
Japan
634.00K
3.42%
European Union (Region)
49.00K
0.26%
Australia
40.00K
0.22%
United Kingdom
35.00K
0.19%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
6.52%
The Vanguard Group, Inc.
5.42%
Geode Capital Management, L.L.C.
2.34%
State Street Global Advisors (US)
1.99%
Opaleye Management Inc.
1.66%
Other
82.05%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
6.52%
The Vanguard Group, Inc.
5.42%
Geode Capital Management, L.L.C.
2.34%
State Street Global Advisors (US)
1.99%
Opaleye Management Inc.
1.66%
Other
82.05%
Shareholder Types
Shareholders
Proportion
Investment Advisor
15.37%
Investment Advisor/Hedge Fund
7.56%
Hedge Fund
2.21%
Research Firm
1.26%
Individual Investor
0.83%
Pension Fund
0.11%
Bank and Trust
0.10%
Insurance Company
0.03%
Other
72.54%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
209
7.26M
27.45%
-1.72M
2025Q1
225
7.35M
27.79%
-1.89M
2024Q4
218
6.78M
25.72%
-2.16M
2024Q3
215
6.40M
24.41%
-2.52M
2024Q2
210
6.40M
24.65%
-3.74M
2024Q1
216
7.55M
29.29%
-2.27M
2023Q4
213
7.36M
28.65%
-3.81M
2023Q3
208
8.37M
32.77%
-2.77M
2023Q2
206
8.16M
32.08%
-1.08M
2023Q1
205
7.71M
30.54%
-1.80M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
1.72M
6.52%
-20.83K
-1.19%
Mar 31, 2025
The Vanguard Group, Inc.
1.43M
5.42%
+10.39K
+0.73%
Mar 31, 2025
Geode Capital Management, L.L.C.
619.71K
2.34%
+22.11K
+3.70%
Mar 31, 2025
State Street Global Advisors (US)
526.95K
1.99%
-8.02K
-1.50%
Mar 31, 2025
Opaleye Management Inc.
440.00K
1.66%
+440.00K
--
Mar 31, 2025
UBS Financial Services, Inc.
344.73K
1.3%
+216.10K
+168.00%
Mar 31, 2025
Northern Trust Investments, Inc.
252.16K
0.95%
+38.49K
+18.02%
Mar 31, 2025
Goldman Sachs & Company, Inc.
117.23K
0.44%
-19.75K
-14.42%
Mar 31, 2025
Marshall Wace LLP
114.09K
0.43%
+114.09K
--
Mar 31, 2025
AQR Capital Management, LLC
98.14K
0.37%
+98.14K
--
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Direxion Daily S&P Biotech Bull 3X Shares
0%
Avantis US Equity ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.03%
Global X Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion0%
Avantis US Equity ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI